HYPERTROPHIC CARDIOMYOPATHY (HCM)
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY (HCM) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY (HCM) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to ease heart blockage in rare HCM form
Disease control Not yet recruitingThis study tests a drug called mavacamten in 132 people with hypertrophic cardiomyopathy (HCM) that blocks the lower part of the heart. The goal is to see if the drug reduces pressure inside the heart during a breathing maneuver over 36 weeks. Participants must have a thickened h…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a daily pill stop strokes before they start in heart muscle disease patients?
Prevention Not yet recruitingThis study tests whether the blood thinner rivaroxaban can prevent strokes in people with hypertrophic cardiomyopathy (HCM) who have abnormal left atrial strain, a marker of future atrial fibrillation. About 532 adults aged 40-80 with HCM and normal heart rhythm but reduced atria…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE3 • Sponsor: Rennes University Hospital • Aim: Prevention
Last updated May 17, 2026 02:07 UTC
-
Heart rhythm mystery: why AFib strikes harder in HCM patients
Knowledge-focused Not yet recruitingThis study looks at why atrial fibrillation (AFib) happens more often and is harder to treat in people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle is thicker than normal. Researchers will study electrical signals in the heart and use advanced imagin…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 02:14 UTC
-
Gene study aims to solve heart drug mystery
Knowledge-focused Not yet recruitingThis study looks at why the heart medication mavacamten works better for some people with hypertrophic cardiomyopathy (a thickened heart muscle) than others. Researchers will check if a person's specific gene that causes the condition, and their natural ability to process drugs, …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Heart energy boost: new MRI study tests Drug's hidden power
Knowledge-focused Not yet recruitingThis study looks at whether a new medication (mavacamten) can improve the energy levels of heart muscle in people with obstructive hypertrophic cardiomyopathy, a condition where the heart muscle thickens and blocks blood flow. Researchers will use a special MRI scan to measure th…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC